G2 arrest in response to topoisomerase II inhibitors: The role of p53

Cancer Research

Volumn 63, Issue 14, 2003, Pages 4074-4081

  Clifford, Brad ^a   Beljin, Milos ^a   Stark, George R ^a   Taylor, William R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; ETOPOSIDE; GYRASE INHIBITOR; MERBARONE; PROTEIN P53; CYCLIN B; DNA TOPOISOMERASE (ATP HYDROLYSING); ENZYME INHIBITOR; THIOBARBITURIC ACID DERIVATIVE;

ARTICLE; ATAXIA TELANGIECTASIA; CELL CYCLE G2 PHASE; CHROMATIN; CONTROLLED STUDY; DNA DAMAGE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; METAPHASE; MITOSIS RATE; PRIORITY JOURNAL; REPORTER GENE; TUMOR CELL; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG INTERACTION; ENZYMOLOGY; FIBROSARCOMA; GENETICS; MITOSIS; PATHOLOGY; PHYSIOLOGY;

CAFFEINE; CDC2 PROTEIN KINASE; CYCLIN B; DNA TOPOISOMERASES, TYPE II; DOWN-REGULATION; DRUG INTERACTIONS; ENZYME INHIBITORS; ETOPOSIDE; FIBROSARCOMA; G2 PHASE; HUMANS; MITOSIS; THIOBARBITURATES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0042674256     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Vogelstein, B., Lane, D., and Levine, A. J. Surfing the p53 network. Nature (Lond.), 408: 307-310, 2000.
2. 1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol., 14: 6264-6277, 1994.
3. Appella, E., and Anderson, C. W. Post-translational modifications and activation of p53 by genotoxic stresses. Eur. J. Biochem., 268: 2764-2772, 2001.
4. 2-M transition by p53. Oncogene, 20: 1803-1815, 2001.
5. Agarwal, M. L., Agarwal, A., Taylor, W. R., Chernova, O., Sharma, Y., and Stark, G. R. A p53-dependent S-phase checkpoint helps to protect cells from DNA damage in response to starvation for pyrimidine nucleotides. Proc. Natl. Acad. Sci. USA, 95: 14775-14780, 1998.
6. 2 checkpoint is maintained by redundant pathways. Mol. Cell. Biol., 19: 5872-5881, 1999.
7. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991.
8. Cliby, W. A., Roberts, C. J., Cimprich, K. A., Stringer, C. M., Lamb, J. R., Schreiber, S. L., and Friend, S. H. Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints. EMBO J., 17: 159-169, 1998.
9. Rudolph, N. S., and Latt, S. A. Flow cytometric analysis of X-ray sensitivity in ataxia telangiectasia. Mutat. Res., 211: 31-41, 1989.
10. Spacey, S. D., Gatti, R. A., and Bebb. G. The molecular basis and clinical management of ataxia telangiectasia. Cancer J. Neurol. Sci., 27: 184-191, 2000.
11. Chaturvedi, P., Eng, W. K., Zhu, Y., Mattern, M. R., Mishra, R., Hurle, M. R., Zhang, X., Annan, R. S., Lu, Q., Faucette, L. F., Scott, G. F., Li, X., Carr, S. A., Johnson, R. K., Winkler, J. D., and Zhou, B. B. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene, 18: 4047-4054, 1999.
12. 2-M DNA damage checkpoint. Genes Dev., 14: 1448-1459, 2000.
13. Matsuoka, S., Rotman, G., Ogawa, A., Shiloh, Y., Tamai, K., and Elledge, S. J. Ataxia telangiectasia-mutated phosphorylates chk2 in vivo and in vitro. Proc. Natl. Acad. Sci. USA. 97: 10389-10394, 2000.
14. Furnari, B., Rhind, N., and Russell, P. Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase [see comments]. Science (Wash. DC), 277: 1495-1497, 1997.
15. Kumagai, A., and Dunphy, W. G. Binding of 14-3-3 proteins and nuclear export control the intracellular localization of the mitotic inducer Cdc25. Genes Dev., 13: 1067-1072, 1999.
16. Lopez-Girona, A., Furnari, B., Mondesert, O., and Russell, P. Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein [see comments]. Nature (Lond.), 397: 172-175, 1999.
17. 2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216 [see comments]. Science (Wash. DC), 277: 1501-1505, 1997.
18. Sanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Piwnica-Worms, H., and Elledge, S. J. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25 [see comments]. Science (Wash. DC), 277: 1497-1501, 1997.
19. Nurse, P. Universal control mechanism regulating onset of M-phase. Nature (Lond.), 344: 503-508, 1990.
20. Pines, J. Cyclins and cyclin-dependent kinases: a biochemical view. Biochem. J., 308: 697-711, 1995.
21. 2 arrest after DNA damage. Science (Wash. DC), 282: 1497-1501, 1998.
22. Blasina, A., Price, B. D., Turenne, G. A., and McGowan, C. H. Caffeine inhibits the checkpoint kinase ATM. Curr. Biol., 9: 1135-1138, 1999.
23. Sarkaria, J. N., Busby, E. C., Tibbetts, R. S., Roos, P., Taya, Y., Karnitz, L. M., and Abraham, R. T. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res., 59: 4375-4382, 1999.
24. 2-M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity. J. Biol. Chem., 275: 10342-10348, 2000.
25. Lau, C. C., and Pardee, A. B. Mechanism by which caffeine potentiates lethality of nitrogen mustard. Proc. Natl. Acad. Sci. USA, 79: 2942-2946, 1982.
26. Fan, S., Smith, M. L., Rivet, D. J., II, Duba, D., Zhan, Q., Kohn, K. W., Fornace, A. J., Jr., and O'Connor, P. M. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline, Cancer Res., 55: 1649-1654, 1995.
27. 2 delay. Cancer Res., 55: 1643-1648, 1995.
28. Jin, S., Antinore, M. J., Lung, F. D., Dong, X., Zhao, H., Fan, F., Colchagie, A. B., Blanck, P., Roller, P. P., Fornace, A. J., Jr., and Zhan, Q. The GADD45 inhibition of Cdc2 kinase correlates with GADD45-mediated growth suppression. J. Biol. Chem., 275: 16602-16608, 2000.
29. 2-M cell cycle checkpoint. Proc. Natl. Acad. Sci. USA, 96: 3706-3711, 1999.
30. Zhan, Q., Antinore, M. J., Wang, X. W., Carrier, F., Smith, M. L., Harris, C. C., and Fornace, A. J., Jr. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45. Oncogene, 18: 2892-2900, 1999.
31. Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W., and Vogelstein, B. 14-3-3σ is required to prevent mitotic catastrophe after DNA damage [see comments]. Nature (Lond.), 401: 616-620, 1999.
32. 2-M progression. Mol Cell., 1: 3-11, 1997.
33. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701-704, 1993.
34. Harper, J. W., Elledge, S. J., Keyomarsi, K., Dynlacht, B., Tsai, L. H., Zhang, P., Dobrowolski, S., Bai, C., Connell-Crowley, L., Swindell, E., et al. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell, 6: 387-400, 1995.
35. 2 DNA damage checkpoint. J. Biol. Chem., 275: 30638-30643, 2000.
36. Ossovskaya, V. S., Mazo, I. A., Chernov, M. V.,. Chernova, O. B., Strezoska, Z., Kondratov, R., Stark, G. R., Chumakov, P. M., and Gudkov, A. V. Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains. Proc. Natl. Acad. Sci. USA, 93: 10309-10314, 1996.
37. 1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA, 92: 8493-8497, 1995.
38. Taylor, W. R., Agarwal, M. L., Agarwal, A., Stacey, D. W., and Stark, G. R. p53 inhibits entry into mitosis when DNA synthesis is blocked. Oncogene, 18. 283-295, 1999.
39. 2-M checkpoints are induced by ionizing irradiation. Mol. Cell. Biol., 22: 1049-1059, 2002.
40. 2 arrest in response to overexpression of p53. Mol. Biol. Cell, 10: 3607-3622, 1999.
41. Taylor, W. R., Schonthal, A. H., Galante, J., and Stark, G. R. p130/E2F4 binds to and represses the cdc2 promoter in response to p53. J. Biol. Chem., 276: 1998-2006, 2001.
42. Crosio, C., Fimia, G. M., Loury, R., Kimura, M., Okano, Y., Zhou, H., Sen, S., Allis, C. D., and Sassone-Corsi, P. Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases. Mol. Cell. Biol., 22: 874-885, 2002.
43. Hsu, J. Y., Sun, Z. W., Li, X., Reuben, M., Tatchell, K., Bishop, D. K., Grushcow, J. M., Brame, C. J., Caldwell, J. A., Hunt, D. F., Lin, R., Smith, M. M., and Allis, C. D. Mitotic phosphorylation of histone H3 is governed by Ip11/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes. Cell, 102: 279-291, 2000.
44. Banin, S., Moyal, L., Shieh, S., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., and Ziv, Y. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science (Wash. DC), 281: 1674-1677, 1998.
45. Canman, C. E., Lim, D. S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., and Siliciano, J. D. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science (Wash. DC), 281: 1677-1679, 1998.
46. Khanna, K. K., Keating, K. E., Kozlov, S., Scott, S., Gatei, M., Hobson, K., Taya, Y., Gabrielli, B., Chan, D., Lees-Miller, S. P., and Lavin, M. F. ATM associates with and phosphorylates p53: mapping the region of interaction. Nat. Genet., 20: 398-400, 1998.
47. Marston, N. J., Jenkins, J. R., and Vousden, K. H. Oligomerisation of full length p53 contributes to the interaction with mdm2 but not HPV E6. Oncogene, 10: 1709-1715, 1995.
48. Froelich-Ammon, S. J., and Osheroff, N. Topoisomerase poisons: harnessing the dark side of enzyme mechanism. J. Biol. Chem., 270: 21429-21432, 1995.
49. Fortune, J. M., and Osheroff, N. Merbarone inhibits the catalytic activity of human topoisomerase IIα by blocking DNA cleavage. J. Biol. Chem., 273: 17643-17650, 1998.
50. Deming, P. B., Cistulli, C. A., Zhao, H., Graves, P. R., Piwnica-Worms, H., Paules, R. S., Downes, C. S., and Kaufmann, W. K. The human decatenation checkpoint. Proc. Natl. Acad. Sci. USA, 98: 12044-12049, 2001.
51. 2 cycle checkpoint in mammalian cells. Nature (Lond.), 372: 467-470, 1994.
52. Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S., and Bonner, W. M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem., 273: 5858-5868, 1998.
53. Yao, S. L., Akhtar, A. J., McKenna, K. A., Bedi, G. C., Sidransky, D., Mabry, M., Ravi, R., Collector, M. I., Jones, R. J., Sharkis, S. J., Fuchs, E. J., and Bedi, A. Selective radiosensitization of p53-deficient cells by caffeine-mediated activation of p34cdc2 kinase. Nat. Med., 2: 1140-1143, 1996.
54. Ward, I. M., and Chen, J. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J. Biol. Chem., 276: 47759-47762, 2001.
55. Lock, R. B., Galperina, O. V., Feldhoff, R. C., and Rhodes, L. J. Concentration-dependent differences in the mechanisms by which caffeine potentiates etoposide cytotoxicity in HeLa cells. Cancer Res., 54: 4933-4939, 1994.